[Featured Stock] LabGenomics Rises on Expectations of Expanded COVID-19 Test Kit Supply
[Asia Economy Reporter Minji Lee] LabGenomics has been on a sharp rise for two consecutive days following news that it is discussing the expansion of supply for its COVID-19 diagnostic kits.
As of 2:55 PM on the 21st in the KOSDAQ market, LabGenomics was trading at 12,800 KRW, up 13.27% from the previous session.
The previous day, LabGenomics announced that it had completed the development of its COVID-19 diagnostic kit and is currently negotiating supply to China. Recently, the company reportedly received an official request for supply of the COVID-19 diagnostic kits from the First People's Hospital of Nanyang City, China.
Hot Picks Today
About 100 Trillion Won at Stake... "Samsung Strike Is an Unprecedented Opportunity" as Prices Surge 20% [Taiwan Chip Column]
- "Anyone Who Visited the Room Salon, Come Forward"… Gangnam Police Station Launches Full Staff Investigation After New Scandal
- "Envious of Korean Daily Life"...Foreign Tourists Line Up in Central Myeongdong from Early Morning [Reportage]
- Woman in Her 50s Found Dead 28 Days After Going Missing on Bukhansan Mountain
- "Heading for 2 Million Won": The Company the Securities Industry Says Not to Doubt [Weekend Money]
A company representative stated, “We are discussing the details of the supply contract in response to the request from the First People's Hospital of Nanyang City,” adding, “We are also receiving inquiries about the diagnostic kits from Europe and are conducting negotiations mainly with existing clients.”
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.